Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants | Science Translational Medicine

Skip to main content

ScienceMag.org

Article Information

vol. 3 no. 88 88ra56

DOI:

https://doi.org/10.1126/scitranslmed.3002461

PubMed:

Published By:

American Association for the Advancement of Science

Print ISSN:

Online ISSN:

History:

Received for publication March 29, 2011
Accepted for publication June 3, 2011
.

Copyright & Usage:

Copyright © 2011, American Association for the Advancement of Science

Author Information

Martin O. C. Ota¹,*,
Aderonke A. Odutola¹,
Patrick K. Owiafe¹,
Simon Donkor¹,
Olumuyiwa A. Owolabi¹,
Nathaniel J. Brittain²,
Nicola Williams³,
Sarah Rowland-Jones¹,
Adrian V. S. Hill²,
Richard A. Adegbola⁴ and
Helen McShane²

¹Bacterial Diseases Programme, Medical Research Council Unit, P. O. Box 273, Banjul, The Gambia.
²Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.
³Centre for Statistics in Medicine, Wolfson College, Linton Road, Oxford OX2, UK.
⁴Bill & Melinda Gates Foundation, Seattle, WA 98102, USA.

↵*To whom correspondence should be addressed. E-mail: mota{at}mrc.gm

Altmetric

Article usage

Article usage: June 2011 to September 2019

	Abstract	Full	Pdf
Jun 2011	2440	64	110
Jul 2011	870	27	54
Aug 2011	364	6	13
Sep 2011	224	7	16
Oct 2011	182	1	7
Nov 2011	184	2	16
Dec 2011	128	4	7
Jan 2012	100	2	3
Feb 2012	86	2	4
Mar 2012	152	5	13
Apr 2012	91	1	6
May 2012	102	2	10
Jun 2012	100	0	12
Jul 2012	68	1	7
Aug 2012	83	7	9
Sep 2012	97	8	15
Oct 2012	77	7	6
Nov 2012	73	7	9
Dec 2012	114	5	5
Jan 2013	91	8	8
Feb 2013	118	8	14
Mar 2013	88	7	6
Apr 2013	144	8	5
May 2013	123	8	9
Jun 2013	141	6	8
Jul 2013	75	3	6
Aug 2013	60	4	9
Sep 2013	57	7	8
Oct 2013	83	1	3
Nov 2013	55	3	3
Dec 2013	45	6	4
Jan 2014	74	6	7
Feb 2014	58	0	3
Mar 2014	61	1	4
Apr 2014	52	6	4
May 2014	40	2	4
Jun 2014	39	3	3
Jul 2014	71	0	1
Aug 2014	44	2	3
Sep 2014	99	4	5
Oct 2014	74	5	5
Nov 2014	64	3	4
Dec 2014	65	0	5
Jan 2015	99	2	6
Feb 2015	42	3	6
Mar 2015	43	6	10
Apr 2015	47	2	5
May 2015	37	2	2
Jun 2015	30	1	3
Jul 2015	29	1	0
Aug 2015	28	1	2
Sep 2015	16	1	3
Oct 2015	6	2	6
Nov 2015	8	3	2
Dec 2015	22	0	2
Jan 2016	42	1	3
Feb 2016	36	0	3
Mar 2016	41	0	2
Apr 2016	30	1	0
May 2016	46	3	3
Jun 2016	55	3	7
Jul 2016	31	2	0
Aug 2016	46	5	2
Sep 2016	34	1	0
Oct 2016	41	0	1
Nov 2016	54	3	3
Dec 2016	23	0	1
Jan 2017	23	2	0
Feb 2017	35	3	0
Mar 2017	74	1	0
Apr 2017	81	0	3
May 2017	50	2	5
Jun 2017	18	0	0
Jul 2017	29	1	0
Aug 2017	35	2	0
Sep 2017	54	2	3
Oct 2017	50	2	0
Nov 2017	62	5	5
Dec 2017	82	2	2
Jan 2018	66	3	1
Feb 2018	63	0	1
Mar 2018	31	4	0
Apr 2018	53	3	2
May 2018	65	1	1
Jun 2018	45	3	0
Jul 2018	20	1	0
Aug 2018	57	4	1
Sep 2018	30	3	2
Oct 2018	31	3	3
Nov 2018	48	12	3
Dec 2018	40	3	0
Jan 2019	22	4	0
Feb 2019	34	2	1
Mar 2019	11	2	0
Apr 2019	13	7	2
May 2019	23	4	0
Jun 2019	22	2	1
Jul 2019	19	2	0
Aug 2019	14	6	3
Sep 2019	7	1	0

Science Translational Medicine: 3 (88)

Science Translational Medicine

Vol 3, Issue 88
22 June 2011

Table of Contents

Article Tools

Email

Thank you for your interest in spreading the word about Science Translational Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email

Your Name

Send To
Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants

Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

Your Personal Message
Download Powerpoint
Print
Save to my folders

Log In with your AAAS Login
Alerts

Please log in to add an alert for this article.

Log In with your AAAS Login

Sign In to Email Alerts with your Email Address
Email
Citation tools
Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants

By Martin O. C. Ota, Aderonke A. Odutola, Patrick K. Owiafe, Simon Donkor, Olumuyiwa A. Owolabi, Nathaniel J. Brittain, Nicola Williams, Sarah Rowland-Jones, Adrian V. S. Hill, Richard A. Adegbola, Helen McShane

Science Translational Medicine22 Jun 2011 : 88ra56

Coadministration with standard vaccines may reduce immunogenicity of tuberculosis vaccine.

Citation Manager Formats

BibTeX

Bookends

EasyBib

EndNote (tagged)

EndNote 8 (xml)

Medlars

Mendeley

Papers

RefWorks Tagged

Ref Manager

RIS

Zotero
Share

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants

By Martin O. C. Ota, Aderonke A. Odutola, Patrick K. Owiafe, Simon Donkor, Olumuyiwa A. Owolabi, Nathaniel J. Brittain, Nicola Williams, Sarah Rowland-Jones, Adrian V. S. Hill, Richard A. Adegbola, Helen McShane

Science Translational Medicine22 Jun 2011 : 88ra56

Coadministration with standard vaccines may reduce immunogenicity of tuberculosis vaccine.

Share This Article:

Citing Articles in: